Table 3.
Patient-Level Attributes | ||||||
---|---|---|---|---|---|---|
Breast Outcomes | Black vs. White | 95% CI | Poverty | 95% CI | No Prior Claims | 95% CI |
Stage local vs. regional/metastatic | 0.80* | 0.75-0.87 | 0.78* | 0.78-0.89 | 0.59* | 0.56-0.62 |
Stage regional vs. metastatic | 0.98 | 0.85-1.12 | 0.78* | 0.69-0.89 | 0.44* | 0.40-0.48 |
Local Control | 0.81* | 0.71-0.92 | 0.78* | 0.69-0.78 | 0.52* | 0.43-0.63 |
Adjuvant Chemotherapy | 1.09 | 0.88-1.35 | 0.69* | 0.54-0.78 | 0.88 | 0.69-1.13 |
Post-Operative Surveillance | 0.76* | 0.66-0.88 | 0.61* | 0.54-0.69 | 0.28* | 0.23-0.34 |
Five Year Survival | 0.92 | 0.82-1.04 | 0.69* | 0.69-0.78 | 0.48* | 0.41-0.56 |
Patient-Level Attributes | ||||||
Colon Outcomes | Black vs. White | 95% CI | Poverty | 95% CI | No Prior Claims | 95% CI |
Stage local vs. regional/metastatic | 0.90* | 0.83-0.97 | 0.89* | 0.89-1.00 | 0.78 | 0.74-0.83 |
Stage regional vs. metastatic | 0.76* | 0.69-0.83 | 0.89* | 0.89-1.00 | 0.71* | 0.66-0.76 |
Local Control | 0.87 | 0.71-1.06 | 0.89* | 0.69-1.00 | 0.88 | 0.65-1.19 |
Adjuvant Chemotherapy | 0.82* | 0.68-1.00 | 0.69* | 0.61-0.78 | 0.42* | 0.34-0.53 |
Post-Operative Surveillance | 0.72* | 0.59-0.87 | 1.13* | 1.00-1.43 | 0.27* | 0.23-0.33 |
Five Year Survival | 0.92 | 0.82-1.04 | 0.78* | 0.78-0.89 | 0.45* | 0.38-0.52 |
Patient-Level Attributes | ||||||
Rectal Outcomes | Black vs. White | 95% CI | Poverty | 95% CI | No Prior Claims | 95% CI |
Stage local vs. regional/metastatic | 0.99 | 0.85-1.14 | 0.89* | 0.78-1.00 | 0.77* | 0.70-0.85 |
Stage regional vs. metastatic | 1.11 | 0.91-1.36 | 0.78* | 0.69-1.00 | 0.65* | 0.57-0.74 |
Local Control | 0.81 | 0.63-1.05 | 0.89 | 0.69-1.00 | 0.62* | 0.47-0.81 |
Adjuvant Chemotherapy | 0.56* | 0.39-0.81 | 0.78 | 0.61-1.13 | 0.39* | 0.27-0.56 |
Post-Operative Surveillance | 0.76 | 0.52-1.11 | 1.00 | 0.69-1.27 | 0.35* | 0.26-0.49 |
Five Year Survival | 0.76* | 0.60-0.97 | 0.89 | 0.78-1.00 | 0.44* | 0.34-0.55 |
Legend: Patient-level ORs from three-level multivariable logistic regressions of SEER-Medicare patients with breast cancer or colorectal cancer. Estimates are adjusted for the following other patient (level I) attributes: age, sex, marital status, comorbidity, and social (Level II) attributes: ZCTA % black and college educated and, ethnic isolation and deprivation scores; and health care (Level III) attributes: hospital beds per 100K people, JCAHO-accredited hospitals per 100K people, screening MDs per 100K people, CRC screening per 100K people, medical oncologists per 100K people, surgeons per 100k people, and radiation oncologists per 100k people; and Census Region. Asterisk (*) indicates statistical significance to p<0.05.